Compositions comprising dexamethasone

US11304961B2 · kind B2 · utility

Assignee

• DEXCEL PHARMA TECHNOLOGIES LTD. · IL

Inventors

• Caterina Kreyenborg · Munster, DE
• Elisabeth Meimberg · Emsdetten, DE
• Corinna Tissen · Senden, DE
• Karl-Heinz Bannefeld · Munster, DE
• Tomer Gold · Herzliya, IL

Key dates

• Filing date: Jan 15, 2020
• Grant date: Apr 19, 2022
• Expiry date: Jan 15, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P7/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.